Ozempic and Wegovy Ease Knee Osteoarthritis Pain in Large Study

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current medications in alleviating symptoms.

Health - The New York Times - November 1

Ozempic reduces knee osteoarthritis pain by almost half: Study

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain ...

Politics - The Hill - October 31

Ozempic and Wegovy may be beneficial in fighting alcohol addiction: Study

The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published Wednesday in JAMA Psychiatry said. The study examined about 228,000 people ...

Politics - The Hill - November 14

Semaglutide linked to reduced arthritis knee pain in people with obesity, study finds

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.

Ozempic and Wegovy considered 'available' after more than 2 years in shortage

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of being considered in shortage by the Food and Drug Administration (FDA). ...

Politics - The Hill - October 30

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.

How a love story launched the company behind Ozempic, Wegovy

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...

Ozempic can lead to muscle mass loss: Study

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Politics - The Hill - November 9

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.

Business - CNBC - October 30

Large herbivores have been living in Yellowstone for 2,300 years: Study

Large herbivores, such as bison and elk, have lived continuously in Yellowstone National Park for more than two millennia, a new study has confirmed. Despite the near-extinction of bison in North ...

Politics - The Hill - October 30

Harvard prof who spent 10 years studying retirees: To ease into 'a satisfying retirement life,' ask yourself 1 question

Harvard Business School professor Teresa M. Amabile shares her best advice for what to do before "leaving work behind" so you can set yourself up for success.

Business - CNBC - Yesterday

Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.

As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.

Health - The New York Times - 4 days ago

Novo Nordisk's Wegovy Sales Beat Expectations

The pharmaceutical giant’s blockbuster weight-loss drug beat sales expectations in the third quarter, sending shares higher in early trade.

Business - The Wall Street Journal - November 6

Employers Get Pressure to Pay for Drugs Like Wegovy

Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.

Business - The Wall Street Journal - 4 days ago

Researchers estimate 136M Americans eligible for Ozempic

As many as 136 million adult Americans may be eligible for Ozempic, researchers estimate. According to a study published Monday in JAMA Network, among the 25,531 participants, 8,504 were eligible ...

Politics - The Hill - 3 days ago

The bear market is coming — and it’s going to be painful

The stock market will not keep going up forever.

Business - MarketWatch - November 5

10-year Treasury yield ends with biggest six-week climb in a year as consumer sentiment rises

U.S. government debt sold off on Friday, giving the 10-year yield its biggest six-week advance in about a year, after data showed consumer sentiment rose this month.

Business - MarketWatch - October 25

Why Cooling Inflation Hasn’t Eased Sticker Shock

The term refers to what we have internalized as the fair price for a product or service. It’s often out of sync with what things now actually cost.

Business - The New York Times - November 1

dLocal, Viva Aerobus partner to ease payments for travellers

World - Yahoo News - November 8

Would removing foreign prisoners ease pressure on jails?

The government is hoping to pass emergency legislation to let out prisoners early to ease overcrowding.

Wegovy's creator invested £6bn in this town. So why is it not booming?

Europe's most valuable company has invested billions in Kalundborg on Denmark's coast - but it has many problems.

Novo Nordisk shares jump 8% after Wegovy sales beat expectations

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.

Business - CNBC - November 6

Not just for weight loss: Wegovy may help curb alcohol addiction

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

Novo Nordisk Launches Wegovy Weight-Loss Drug in China

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.

Business - The Wall Street Journal - 4 days ago

Scientist behind Ozempic started her career developing laundry detergent

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry detergent.

Ozempic maker Novo Nordisk nudges higher profit forecast

Novo Nordisk on Wednesday nudged higher its outlook for the year as the drugmaker registered another quarter of strong sales of its weight-loss drugs.

Business - MarketWatch - November 6

Why Is There So Much Off-Brand Oral Ozempic for Sale Online?

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions online, despite a lack of evidence that they work.

Tech - Wired - 3 days ago

The New York Times Presents: ‘Weight of the World’ on Ozempic’s Rise

As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys — and explores how decades of diet culture paved the way for the drugs’ ...

Top stories - The New York Times - Yesterday

We must learn lessons from history, King tells Commonwealth

Some Commonwealth countries have called for the UK to pay reparations for its historic role in the transatlantic slave trade.

She was in pain for years. A rare condition was to blame.

Jill Becher spent more than three years in agonizing pain. After one surgery failed, a riskier treatment provided relief.

Feel it in your bones: taking the pain out of osteoporosis

More than half the women in the UK over the age of 50 will suffer a fracture. But can more awareness – and some heavy lifting – help us beat many of the effects of osteoporosis?. Imagine a room ...

World - The Guardian - October 27

Israel’s attack leaves Iran with a difficult dilemma

Key pillars of Tehran’s security strategy have been shaken by these strikes

Business - Financial Times - October 27

UK Budget: What to Know Before Labour’s Announcement

The new Labour Party government said it had inherited a challenging financial position and warned of tax increases and spending cuts when it reveals its budget this week.

Top stories - The New York Times - October 28

In Spanish Town Devastated by Flood, a Grim Search for Bodies

Rescuers in Paiporta, where more than 60 people died, were still pulling bodies from the mud. “We are alive,” a resident said. “But we have lost everything.”

Top stories - The New York Times - November 1

'Players playing in pain' - Guardiola on injury 'emergency'

Manchester City manager Pep Guardiola says even fit players are in pain as they push themselves through the fixture schedule.

UK ministers admit to Brexit pains, but the relief is on hold

Pro-Europeans granted opening to campaign on single issues that strengthen UK-EU ties

World - Financial Times - November 15

Latest in Ozempic and Wegovy Ease Knee Osteoarthritis Pain in Large Study